Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center found that chemotherapy results in increased heterogeneity within the tumor, leading to the evolution of multiple resistance mechanisms.
The research team, led by Lauren Averett...
If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study led by The University of Texas MD...
Founding TMC3 institutions – Texas Medical Center (TMC), Baylor College of Medicine, Texas A&M University Health Science Center, The University...
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease, researchers at The University of Texas MD Anderson Cancer Center report in Nature Medicine.
Their research provided the scientific underpinning for clinical trials under way of the drug poziotinib against non-small-cell lung cancer that has a specific alteration...
Triple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast cancers. It is a scary...
The University of Texas MD Anderson Cancer Center will host free skin cancer screenings from 10 a.m. – 1 p.m. on Saturday, May 5 at two of...
Richard D. Wood, Ph.D., professor at The University of Texas MD Anderson Cancer Center, has been elected as a member of the American Academy...
A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the...
Just like people, some T cells have excellent memories. These subtypes known as memory T cells may explain why some immunotherapies are more...
Special Note: All prom events are open to media, including the dress and tux selection, and hair and makeup appointments.
The...
Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk, display immune system activation...
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug...
Country music fans and polo enthusiasts alike are expected at the 32nd annual Polo on the Prairie, an annual polo match and fundraising event...
Researchers from The University of Texas MD Anderson Cancer Center have found a startling amount of new information about molecular features...
At the heart of any cancer diagnosis or treatment are cells. If one thinks of the cell components controlling gene activation as a Russian...